Locksley Announces Oversubscribed A$17 Million Placement Lead by U.S. Investors Funding to Accelerate Execution of Locksley's U.S. Mine to Market Strategy

Locksley Announces Oversubscribed A$17 Million Placement Lead by U.S. Investors Funding to Accelerate Execution of Locksley's U.S. Mine to Market Strategy

SAN BERNARDINO, Calif., Dec. 8, 2025 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY/OTCQX: LKYRF/ADR: LKYLY) announced the successful completion of a heavily oversubscribed capital raising, securing firm commitments to raise approximately A$17...

Hyundai Mobis Establishes Additional SW R&D Hub in Bengaluru, India

Hyundai Mobis Establishes Additional SW R&D Hub in Bengaluru, India

Following the establishment of the integrated R&D center in Hyderabad earlier this year, the company is cultivating a locally self-contained SW hub in the IT-centric city of Bengaluru Securing additional top-tier local software talent to enhance...

DAR GLOBAL AND ART DISTRICT REAL ESTATE DEVELOPMENT ANNOUNCE 'MAD', MUSCAT'S MARINE, ART & DIGITAL DISTRICT

DAR GLOBAL AND ART DISTRICT REAL ESTATE DEVELOPMENT ANNOUNCE 'MAD', MUSCAT'S MARINE, ART & DIGITAL DISTRICT

MUSCAT, Oman, Dec. 8, 2025 /PRNewswire/ -- Dar Global (LSE: DAR), the London-listed luxury real estate developer, in partnership with Art District Real Estate Development, today announced the start of the collaboration to launch and develop 'MAD',...

CUHK Business School Launches CII 3.0: From Assessment to Practice, Leading a New Phase in Corporate Innovation

CUHK Business School Launches CII 3.0: From Assessment to Practice, Leading a New Phase in Corporate Innovation

HONG KONG, Dec. 5, 2025 /PRNewswire/ -- On 5 December 2025, The Asia-Pacific Institute of Business (APIB) at the Chinese University of Hong Kong (CUHK) Business School officially launched the third phase of the Corporate Innovation Index 3.0 (CII...

Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics

Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics

Companies to advance CR-001, a PD-1 x VEGF bispecific antibody, and SKB105, an integrin beta-6-directed antibody-drug conjugate (ADC), in global markets and China Collaboration designed to accelerate and expand the development of synergistic...

Riyadh to Host the Third Edition of the Global Labor Market Conference in January

Riyadh to Host the Third Edition of the Global Labor Market Conference in January

RIYADH, Saudi Arabia, Dec. 1, 2025 /PRNewswire/ -- Under the patronage of the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, the Ministry of Human Resources and Social Development has announced that it will host the third...

Chinese Creativity Empowers the World: EPWK Builds a "Digital Silk Road" for Cross-Border Services

Chinese Creativity Empowers the World: EPWK Builds a "Digital Silk Road" for Cross-Border Services

XIAMEN, China, Nov. 27, 2025 /PRNewswire/ -- "Through the projects on the platform, I can quickly sense design trends in the Chinese market, which inspires my other design work. At the same time, the professional matching and fund escrow mechanisms...

New micromobility concepts for increased sustainability in urban traffic: BMW Group grants licenses to the LUYUAN Group

New micromobility concepts for increased sustainability in urban traffic: BMW Group grants licenses to the LUYUAN Group

HANGZHOU, China, Nov. 26, 2025 /PRNewswire/ -- The BMW Group has officially granted licenses for two of its micromobility concepts to its partner, the LUYUAN Group, during a signing ceremony today. The licensed concepts, "Dynamic Cargo" and "Clever...

FGR secures exclusive global graphene carbon paste production and sale rights

FGR secures exclusive global graphene carbon paste production and sale rights

Highlights First Graphene enters exclusive agreement to develop, produce, market and sell graphene-based carbon paste products with Halocell Australia Carbon paste is a conductive coating used to improve performance across a range of flexible...

ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics

ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics

Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology Pursues a "once-and-done" treatment paradigm for diseases with high unmet medical needs SEOUL, South Korea, Nov....

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 19
  • menu
    menu